for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Tilray Inc

TLRY.O

Latest Trade

22.12USD

Change

1.46(+7.07%)

Volume

2,134,409

Today's Range

21.05

 - 

22.50

52 Week Range

20.20

 - 

178.85

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
20.66
Open
21.45
Volume
2,134,409
3M AVG Volume
36.32
Today's High
22.50
Today's Low
21.05
52 Week High
178.85
52 Week Low
20.20
Shares Out (MIL)
114.31
Market Cap (MIL)
2,046.64
Forward P/E
-17.23
Dividend (Yield %)
--

Latest Developments

More

Fluent Beverage Co Announces Plans To Commercialize Non-Alcohol CBD-Infused Beverages In Canada

Tilray And Privateer Holdings Sign Deal To Extend Lock-Up And Provide For Orderly Distribution Of 75 Million Tilray Shares Held By Privateer

Tilray Announces Definitive Agreement To Acquire FOUR20 Adult-Use Cannabis Retailer

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Tilray Inc

Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

Industry

Biotechnology & Drugs

Contact Info

1100 Maughan Rd

+1.416.9342141

https://www.tilray.com/

Executive Leadership

Brendan Kennedy

President, Chief Executive Officer, Director

Mark Castaneda

Chief Financial Officer, Treasurer, Secretary

Kristina Adamski

Executive Vice President, Corporate Affairs

Edward Wood Pastorius

Chief Revenue Officer

Andrew Pucher

Chief Corporate Development

Key Stats

2.78 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.0K

2019(E)

0.2K
EPS (USD)

2018

-0.780

2019(E)

-1.217
Price To Earnings (TTM)
--
Price To Sales (TTM)
21.65
Price To Book (MRQ)
5.67
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
120.69
LT Debt To Equity (MRQ)
120.62
Return on Investment (TTM)
-25.80
Return on Equity (TTM)
-20.35

Latest News

Latest News

Cannabis firm Tilray posts bigger quarterly loss as investments weigh

Canadian pot producer Tilray Inc <TLRY.O> reported a bigger quarterly loss on Tuesday, as it ramped up investments to boost production in an attempt to grab a larger share of the nascent cannabis market and expand internationally.

UPDATE 2-Cannabis firm Tilray sees growth slowing, loss nearly triples as investments weigh

Canadian pot producer Tilray Inc reported a wider-than-expected quarterly loss on Tuesday, as it ramped up investments to boost production and warned of muted growth in the Canadian recreational marijuana market for the second half of the year.

Tilray CFO says co will not be profitable for at least a year: Bloomberg

Cannabis producer Tilray Inc will not make profit for at least another year, Bloomberg reported on Monday, quoting the company's chief financial officer.

Tilray CFO says co will not be profitable for at least a year - Bloomberg

Cannabis producer Tilray Inc will not generate positive earnings for at least another year, Bloomberg reported https://www.bloomberg.com/news/articles/2019-06-10/tilray-won-t-be-profitable-for-at-least-a-year-cfo-says on Monday, quoting the company's chief financial officer.

Tilray, Aurora Cannabis sales jump after Canada legalizes recreational marijuana

Cannabis producers Tilray Inc and Aurora Cannabis Inc on Tuesday reported a surge in quarterly revenue, boosted by increased demand following the legalization of recreational cannabis in Canada.

Tilray posts bigger quarterly loss due to higher costs

Canada's Tilray Inc reported a bigger quarterly loss on Tuesday, as the cannabis producer ramped up investments, acquired a hemp-based food maker and expanded internationally.

Tilray to buy hemp food maker for about C$419 million, shares rise

Shares of Canadian cannabis firm Tilray Inc rose as much as 7 percent on Wednesday after announcing a deal to buy hemp food maker Manitoba Harvest for up to C$419 million ($318 million) as it seeks to gain a foothold in the lucrative business.

Brewer AB InBev partners with Tilray to tap cannabis drink market

Anheuser-Busch InBev <ABI.BR>, the world's largest brewer, and Canadian pot producer Tilray Inc <TLRY.O> are partnering in a $100-million joint venture to research cannabis-infused non-alcoholic drinks for the Canadian market, the companies said Wednesday.

Cannabis firm Tilray shares pull back on bigger-than-expected loss

Canadian cannabis producer Tilray Inc <TLRY.O> reported an 86 percent jump in third-quarter revenue on Tuesday, but a wider-than-expected loss weighed on shares in after-hours trading.

Cannabis firm Tilray 3rd qtr revenue climbs 86 pct

Canadian cannabis producer Tilray Inc said on Tuesday its third-quarter revenue rose 86 percent to $10 million (13.24 million Canadian dollars), compared with the consensus analyst estimate of $10.1 million.

Citron's Left calls Tilray surge its 'worst day ever' in market

Andrew Left, one of Wall Street's most prominent short-sellers, said Tilray Inc gave his firm its "worst day ever in the market" two months ago when its shares almost doubled in one session, but he remains bearish on the Canadian cannabis company.

Tilray options on fire as pot-stock frenzy grips market

The meteoric rise this week of Tilray Inc's <TLRY.O> share price unleashed a rush of speculative activity in options on the medical marijuana company and other marijuana-related names, data showed on Wednesday.

Cannabis firm Tilray revenue almost doubles, shares climb

Tilray Inc <TLRY.O>, which listed on the Nasdaq on July 19, rose 3.9 percent in after hours trade on Tuesday after reporting its second-quarter revenue almost doubled to $9.7 million (12.66 million Canadian dollars).

Canadian cannabis producer Tilray Q2 revenue almost doubles

Canadian cannabis producer Tilray Inc said on Tuesday its second-quarter revenue almost doubled to $9.7 million (12.66 million Canadian dollars), beating analyst expectations for $9 million.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up